Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation?
A K Webb, J Egan A medical issue currently causing much discussion in cystic centres which have not yet adopted a segregation policy. 19 Demand for donor organs currently exceeds a decreasing fibrosis centres and transplant units is the concern that patients with cystic fibrosis colonised with Burkholderia supply and a third of all patients with cystic fibrosis listed for transplantation die on the waiting list. 20 Death rates cepacia may have a poor outcome following transplantation.
1 2 As the supply of donor organs continues to from road traffic accidents and intracranial haemorrhage have decreased because of active strategies to resolve these decline, the question arises as to whether these patients should be excluded from transplantation. Is there sufficient problems. The donor pool may also be reduced in countries with limited availability of intensive care beds. Great variclinical and scientific information to reach a decision to exclude this group of patients from lung transplantation, ability also exists between regions in the UK for rates of lung donation -for example, in 1994 there were 7.1 which offers increased survival? Are there any solutions? Is such a decision ethically correct? Many issues need to cadaveric thoracic organ donations per million population (PMP) made in the North West of England compared with be carefully addressed before such a finite conclusion is reached.
9.8 PMP for the Northern/Yorkshire region which suggests that local factors may influence donor rates. Burkholderia cepacia, previously recognised as a plant pathogen (Latin cepia=onion), emerged in the early 1980s
New approaches have been advocated to improve organ donation. Continuing education to medical and nursing as a human pathogen. It has a particular predisposition to infect patients with cystic fibrosis. Infection with B cepacia staff on the beneficial aspects of transplantation is crucial to increase limited organ donation. In Spain there has been is distinguished from infection with other major cystic fibrosis pathogens such as Pseudomonas aeruginosa by a 40% increase in the rate of organ donation on the basis of constructing a widespread coordination network which accelerated lung disease in some patients with mild to moderate lung disease.
3-6 Overwhelming septicaemia and focuses on donor detection rather than only concentrating on retrieval. Emphasis on skilled family communication necrotising pneumonia due to B cepacia are well described, [5] [6] [7] 
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The United States Cystic Fibrosis Foundation registry patients with cystic fibrosis infected with B cepacia. 1 2 However, in 50% of those patients infected with B cepacia the report published in 1994 identified 538 patients (3.2%) growing B cepacia. A current epidemiological survey has organism was identified for the first time after transplantation. This implies either the organism was not idenidentified 221 (6%) B cepacia positive patients in the UK and 333 (5%) B cepacia positive patients in Europe.
tified by appropriate microbiological techniques prior to transplantation or the organism was acquired following Worldwide there is therefore a small but significant number of patients infected with B cepacia who potentially will transplant surgery. Following transplantation patients are vulnerable to nosocomial infections. Spread of B cepacia need a transplant.
Although the numbers of patients with cystic fibrosis in non-cystic fibrosis immunocompromised patients is well recognised. 22 In contrast, two subsequent reports -one infected with B cepacia are relatively small, the current prevalence is likely to persist. Epidemiological studies using from North America and one from the UK -found no excess mortality following transplantation in those patients bacteriocin typing, multilocus enzyme electrophoresis, PCR ribotyping, and pulsed-field gel electrophoresis have infected with B cepacia. 23 24 In a report from the UK the combined data from three separate transplant programmes shown that B cepacia may be highly transmissible between patients. [12] [13] [14] [15] Cross infection occurs usually by direct perdid not find a greater mortality in 14 patients colonised with B cepacia. In a report from North Carolina 12 B son-to-person spread; a third party source is uncommon. Some strains may be more transmissible than others. An cepacia positive patients had a similar outcome to other transplanted patients. 23 epidemic strain is described with novel cable pili which bind to cystic fibrosis mucin and epithelial cell receptors. 15 16 It is appropriate at this point to note that organisms other than B cepacia may potentially affect clinical The incidence of B cepacia is now declining as a consequence of strict segregation policies in cystic fibrosis outcome following transplantation. These organisms can include multiple resistant pseudomonads, methicillin recentres in North America and the UK. 13 17 Although some centres have described the end of their epidemic, 6 sistant staphylococcus (MRSA), Aspergillus fumigatus, Xanthomonas maltophilia, and B gladioli. Two recent studies segregation strategies have not completely eliminated acquisition because transmission still occurs between have shown that the presence of these resistant organisms in patients with cystic fibrosis before transplantation does B cepacia positive and negative patients who congregate socially. 18 Outbreaks are also described in cystic fibrosis not predict a worse outcome following transplantation than Is it ethical to exclude from transplantation a significant interaction which can identify "at risk" patients. Prognostic statements on the clinical consequences of colonisation are number of patients with cystic fibrosis infected with B cepacia? To deny them the opportunity would be to dimindifficult; even in epidemic outbreaks when patients are colonised by the same strain, some patients may remain ish any hope of a future. Are risk factors, limited organ supply, potential postoperative problems, and health ecoasymptomatic whilst others succumb to rapid fatal decline. 6 13 nomics good enough reasons to make a decision of exclusion? Should there exist an aristocracy of the more Members of the species presently identified as B cepacia are heterogeneous both in their genomic and phenotypic fortunate? It can be argued on ethical grounds that health care (in this case, transplantation) requires that each patient profile. [28] [29] [30] One study identified more than 50 ribotype patterns in 178 patients. 11 In the same study, isolates of with cystic fibrosis, irrespective of infecting organism or risk, is entitled to the opportunity of having a transplant an epidemic strain with the same genomic profile showed a very variable antibiotic susceptibility. In our unit six as long as there is a chance of benefit. 34 Against this precept is the decreasing supply of donor organs and the most patients have eliminated the organism from their sputum for more than three years and another five are colonised effective way of using this limited resource. These are difficult issues, but until there is unequivocal intermittently. Other units have noted similar findings.
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Identifying differing host responses in those patients evidence of an absence of benefit for patients with B cepacia who undergo transplantation, an equitable approach ought infected with B cepacia may be just as important as the virulence of the organism. A UK multicentre study has to be applied -that is, equal access for equal needs. Above all, the emphasis should remain on improving shown that the exaggerated host response, characteristic of cystic fibrosis, is greatest in the presence of infection donor availability rather than excluding patients from transplantation. with B cepacia; levels of the inflammatory markers Creactive protein and neutrophil elastase 1 -antiproteinase We are indebted to Drs A Woodcock, M Dodd, D Stableforth, J Harris, and J complex were significantly higher during B cepacia asGovan for their robust comments in the preparation of this manuscript. sociated exacerbations than in exacerbations due to P aeruginosa alone. 31 The lipopolysaccharide of B cepacia 
